Medical Advocates
HCV Infection/Disease
  Liver Transplants

General Reports
Transplant Criteria
nt face="Arial Black" size="4">Donor Studies
Waiting Lists
Post-Transplant Treatment/Drugs
HIV/HCV Transplants
HCV Recurrence



 
HCV Treatment Main New/Newsworthy Disease Index      
Last Update:  May 27, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 
          Journal Papers, Abstracts, and Commentaries
 
 
Prevalent immunosuppressive strategies in liver transplantation for hepatitis C: results of a multi-center international
survey.
 Gedaly R, Clifford TM, McHugh PP, et al
Transpl Int. 2008 May 21
 Abstract
 
Controversies in liver transplantation for hepatitis C.
 Mukherjee S, Sorrell MF.
Gastroenterology. 2008 May;134(6):1777-88.
 Abstract
 
Liver retransplantation of patients with hepatitis C infection is associated with acceptable
patient and graft survival.
 Ghabril M, Dickson RC, Machicao VI, et al
L:iver Transpl. 2007 Nov 28;13(12):1717-1727
Abstract
 
Management of hepatitis C virus in the transplant patient.
 Berenguer M.
 Clin Liver Dis. 2007 May;11(2):355-76.
 Abstract
 
FULL TEXT ARTICLE
Liver transplant and hepatitis C in methadone maintenance therapy: a case report.
Hancock MM, Prosser CC, Ransibrahmanakul K, et al 
Subst Abuse Treat Prev Policy. 2007 Feb 1;2(1):5
Paper
 
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver
transplantation.
Terrault NA, Shiffman ML, Lok AS, et al
 Liver Transpl. 2006 Dec 27;13(1):122-129
 Abstract 
 
Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
Khettry U, Huang WY, Simpson MA, et al
 Hum Pathol. 2006 Dec 21;
 Abstract 
 
Scarce influence of corticosteroid boluses on long-term viral load and liver histology in
transplanted patients with recurrent hepatitis C.
 Barcena R, Oton E, Barreales M, et al
Transplant Proc. 2006 Oct;38(8):2502-4.
Abstract 
 
Waiting for a liver transplant: psychosocial well-being, spirituality, and need for counselling.
 Goetzmann L, Wagner-Huber R 
Transplant Proc. 2006 Nov;38(9):2931-6.
 Abstract 
 
Recurrent hepatitis C post-transplantation: Where are we now and where do we go from here?
A report from the Canadian transplant hepatology workshop.
Watt KD, Burak K, Deschenes M, et al
 Can J Gastroenterol. 2006 Nov;20(11):725-734.
 Abstract 

The status of liver transplantation for hepatitis C.
Cameron AM, Busuttil RW.
Expert Opin Biol Ther. 2006 Oct;6(10):993-1002.
 Abstract 

Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV:
results of a phase 2 randomized study.
Schiano TD, Charlton M, Younossi Z,et al
Liver Transpl. 2006 Sep;12(9):1381-9.
Abstract
 
Aspects of hepatitis C virus infection relating to liver transplantation.
Roche B, Samuel D.
Eur J Gastroenterol Hepatol. 2006 Apr;18(4):313-20.
 Abstract
 
Management of hepatitis C in liver transplant recipients.
Kuo A, Terrault NA.
Am J Transplant. 2006 Mar;6(3):449-58.
 Abstract
 
Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-
positive patients.
Takada Y, Haga H, Ito T, et al
 Transplantation. 2006 Feb 15;81(3):350-4.
Abstract
 
FULL-TEXT ARTICLE
A practical approach to managing patients with HCV infection.
Huang RH, Hu KQ.
Int J Med Sci. 2006;3(2):63-8
 Paper
 
Management of hepatitis C-infected liver transplant recipients at large North American centres:
changes in recent years.
Khalili M, Vardanian AJ, Hamerski CM, et al
Clin Transplant. 2006 Jan-Feb;20(1):1-9.
 Abstract
 
FULL-TEXT ARTICLE
Management of HCV infection and liver transplantation.
Schiano TD, Martin P.
Int J Med Sci. 2006;3(2):79-83.
 Paper
 
Epidemiologic trends in infection, mortality, and transplants related to hepatitis C
in Wisconsin.
Gasiorowicz M, Hurie M, Russell A, et al
 WMJ. 2006 Jan;105(1):34-9.
 Abstract
 
Liver transplantation for hepatitis C virus related liver disease.
Gee I, Alexander G.
Postgrad Med J. 2005 Dec;81(962):765-71.
 Abstract
 
Advances and limitations of liver transplantation in Germany
Beckebaum S, Cicinnati VR, Broelsch CE.
Verh Dtsch Ges Pathol. 2004;88:45-50.
 Abstract
 
Transplant Criteria
 
          Journal Papers, Abstracts, and Commentaries
 
  Use of extended criteria livers decreases wait time for liver transplantation without adversely
impacting posttransplant survival.
Tector AJ, Mangus RS, Chestovich P, et al
 Ann Surg. 2006 Sep;244(3):439-50.
 Abstract		  
Donor Studies
 
          Journal Papers, Abstracts, and Commentaries
 
  Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after
liver transplantation.
 Langrehr JM, Puhl G, Bahra M, Schmeding M, et al
 Liver Transpl. 2006 Apr;12(4):644-51
 Abstract
 
Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological
recurrence when compared to deceased donor liver transplantation recipients.
Guo L, Orrego M, Rodriguez-Luna H,
Liver Transpl. 2006 Apr;12(4):560-5.
Abstract
 
Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-
positive patients.
 Takada Y, Haga H, Ito T, et al
 Transplantation. 2006 Feb 15;81(3):350-4.
Abstract
 
Impact of donor age and year of transplantation on graft and patient survival following liver
transplantation for hepatitis C virus.
Mutimer DJ, Gunson B, Chen J, et al
Transplantation. 2006 Jan 15;81(1):7-14.
 Abstract
 
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts
from living versus deceased donors.
Schiano TD, Gutierrez JA, Walewski JL
Hepatology. 2005 Dec;42(6):1420-8.
Abstract
 
Waiting Lists
 
          Journal Papers, Abstracts, and Commentaries
 
  Serologic profile in hepatitis B virus and hepatitis C virus in a Brazilian liver transplant
waiting list.
Almeida RA, Silva GF, Llanos JC
 Transplant Proc. 2006 Jul-Aug;38(6):1920-1
 Abstract
 		  

HCV Treatment Main New/Newsworthy Disease Index